Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs)

○Kazumi Sano

2:00 PM - 4:30 PM

[28P-pm160] Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs)

○Kazumi Sano¹, Yuto Izumi¹, Momoka Kikkawa¹, Haruka Saito¹, Hikaru Nishizawa¹, Hideyuki Nishijima¹, Yoji Ikegami¹, Kazuhiko Nakadate¹, Toshiro Fukami¹, Kazuhiko Hanada¹ (1. Meiji Pharm. Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[28P-pm] 新薬・剤形の開発／医薬品情報③／地域医療④／医薬品適正使用②／薬物治療（臨床・がん）③／医療薬学（その他）③

[28P-pm160] Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs)

Password